ClinicalTrials.Veeva

Menu

Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Irritable Bowel Syndrome
Tight Junction Alteration
Pathophysiology

Treatments

Procedure: colonoscopic mucosal biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT03675100
B-1305/202-003

Details and patient eligibility

About

To evaluate the role of neurotrophic factors (NGF, GDNF, TRPV-1), to quantity tight junction proteins (ZO-1, occludin, claudin) and cytokines (IL-8, TNF-a, IL-1b) in the colonic mucosa of IBS patients and also clarify sex differences in the pathophysiology of IBS.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Control group Those who were between 18 and 80 years old and did not have any abnormalities in colonoscopy
  • Irritable bowel syndrome group Patients who diagnosed as irritable bowel syndrome according to the ROME III criteria

Exclusion criteria

  • history of IBD
  • abdominal operation
  • severe systemic disease
  • malignancy,

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

IBS group
Sham Comparator group
Description:
Patients who were diagnosed with IBS according to the ROME III criteria. Colonoscopic mucosal biopsy was undertaken for every subject.
Treatment:
Procedure: colonoscopic mucosal biopsy
Control group
Active Comparator group
Description:
Healthy participants who have no gastrointestinal symptoms and no colonoscopic abnormality. Colonoscopic mucosal biopsy was undertaken for every subject.
Treatment:
Procedure: colonoscopic mucosal biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems